Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors
Journal of Clinical Pharmacy and Therapeutics,  Clinical Article

Salama MM et al. – There is inter–individual variability in response to the antiplatelet effect of standard doses of aspirin (150, 300 mg/day). The response to aspirin 300 mg/day is enhanced in resistant patients when compared to 150 mg/day. There was a significant association between aspirin resistance and atherothrombotic risk factors (diabetes, hyperlipidaemia and obesity).

Methods
  • The antiplatelet effect of 150 mg/day aspirin was studied prospectively in 50 consecutive patients with unstable angina or non–ST–segment elevation myocardial infarction.
  • Platelet aggregation was measured using optical platelet aggregometry and serum thromboxane B2 level.
  • Aspirin resistance was defined as collagen (1 μg/mL) and adenosine diphosphate (ADP) (5 μmol/L)–induced platelet aggregation of ≥40% when compared with control values.
  • Twenty healthy age– and sex–matched individuals were taken as a control group.
  • All patients were subjected to complete medical history (risk factors, medications), thorough clinical examination, ECG, coronary angiography and laboratory investigations including: complete haemogram, coagulation, kidney, liver and lipid profiles, fasting blood glucose and glycated haemoglobin (HbA1C).

Results
  • Eleven of 50 patients (22%) were found to be aspirin resistant.
  • A highly significant difference was found between the mean values of ADP, collagen–induced platelet aggregation percentage and thromboxane B2 level after aspirin 150 mg/day when compared with the corresponding mean values after aspirin 300 mg/day among the resistant patients (66 ± 7•01%, 62 ± 4•34% and 620 ± 64•58 pg/mL, respectively, vs. 26•87 ± 2•85%, 16•5 ± 3•8% and 77 ± 11•3 pg/mL) indicating enhanced response to aspirin after escalating the dose.
  • The presence of atherothrombotic risk factors (hypertension, smoking, family history of ischaemic heart disease and previous MI) were not statistically different between aspirin–resistant and aspirin–sensitive patients.
  • However, there was a highly significant difference between the aspirin sensitive and the resistant patients regarding the other risk factors (diabetes mellitus and dyslipidaemia) (P < 0•01).

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Physician Assistant

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Physician Assistant Articles

1 Dengue outlook for the World Cup in Brazil: An early warning model framework driven by real-time seasonal climate forecasts The Lancet Infectious Diseases, May 27, 2014    Clinical Article

2 Dance for Parkinson's: A new framework for research on its physical, mental, emotional, and social benefits Complementary Therapies in Medicine, June 17, 2014    Review Article

3 Yogurt and weight management American Journal of Clinical Nutrition, April 3, 2014    Review Article

4 Statins in the elderly: an answered question Current Opinion in Cardiology, June 9, 2014    Evidence Based Medicine    Review Article    Clinical Article

5 The role of vitamin supplementation in the prevention of cardiovascular disease events Full Text Clinical Cardiology, May 30, 2014    Free full text    Review Article

6 Effects of low dose versus high dose human growth hormone on body composition and lipids in adults with GH deficiency: A meta-analysis of placebo-controlled randomized trials Pituitary, May 9, 2014    Evidence Based Medicine    Review Article

7 Tea consumption and the risk of five major cancers: A dose-response meta-analysis of prospective studies Full Text BMC Cancer, March 18, 2014    Free full text    Evidence Based Medicine    Review Article

8 Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States BMJ, June 24, 2014    Evidence Based Medicine    Clinical Article

9 The effectiveness of metoprolol versus atenolol on prevention of all-cause and cardiovascular mortality in a large Chinese population: A cohort study International Journal of Cardiology, June 27, 2014    Clinical Article

10 Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis New England Journal of Medicine, May 21, 2014    Evidence Based Medicine    Clinical Article

11 Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. preventive services task force Annals of Internal Medicine, April 8, 2014    Evidence Based Medicine    Clinical Article

12 The effectiveness of yoga for depression: a critical literature review Issues in Mental Health Nursing, April 9, 2014    Review Article

13 Fish consumption and lung cancer risk: systematic review and meta-analysis Nutrition and Cancer, April 18, 2014    Evidence Based Medicine    Review Article

14 A systematic review of recommendations and guidelines for the management of osteoarthritis: The Chronic Osteoarthritis Management Initiative of the U.S. Bone and Joint Initiative Seminars in Arthritis and Rheumatism, June 19, 2014    Review Article

15 Cardiovascular risk and statin use in the United States Full Text Annals of Family Medicine, May 13, 2014    Free full text    Clinical Article

16 Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care BMJ, June 16, 2014    Evidence Based Medicine    Clinical Article

17 Tofacitinib versus methotrexate in rheumatoid arthritis New England Journal of Medicine, June 20, 2014    Evidence Based Medicine    Clinical Article

18 Statins and physical activity in older men the osteoporotic fractures in men study JAMA Internal Medicine, June 12, 2014    Evidence Based Medicine    Clinical Article

19 Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial The Lancet Oncology, June 18, 2014    Clinical Article

20 Naloxegol for opioid-induced constipation in patients with noncancer pain New England Journal of Medicine, June 13, 2014    Evidence Based Medicine    Clinical Article

Indexed Journals in Physician Assistant: Advance for Physicians Assistants, American Family Physicianmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close